注射用伏立康唑药物利用评价标准的建立和应用  被引量:4

Establishment and application of DUE criteria for IV administration of voriconazole

在线阅读下载全文

作  者:李浩[1] 程娟 郑晓青[1] 张磊[1] 朱娜 周宬玥 吴健 LI Hao;CHENG Juan;ZHENG Xiaoqing;ZHANG Lei;ZHU Na;ZHOU Chengyue;WU Jian(Department of Pharmacy,the Fourth Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China;Department of Pharmacy,the First Affiliated Hospital of University of Science and Technology of China,Hefei 230036,Anhui,China;the First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230000,Anhui,China)

机构地区:[1]安徽医科大学第四附属医院药剂科 [2]中国科学技术大学附属第一医院南区药剂科 [3]安徽中医药大学第一附属医院

出  处:《中国临床药理学与治疗学》2018年第12期1420-1424,共5页Chinese Journal of Clinical Pharmacology and Therapeutics

基  金:安徽省高校自然科学研究重点项目(KJ2017A282)

摘  要:目的:建立注射用伏立康唑药物利用评价(DUE)标准,为临床合理用药提供参考。方法:以注射用伏立康唑药品说明书为基础,参照相关规范、指南和文献,建立注射用伏立康唑DUE标准;并以此为依据,采用回顾性研究方法,对我院2017年7月至2018年7月121例使用注射用伏立康唑住院患者的用药指征、用药过程、用药结果、管理指标等进行综合评价分析。结果:用药指征符合标准百分率为66. 9%(目标值为90%);给药途径、溶媒选择、配制方法符合标准百分率为100%(目标值为100%);给药剂量和疗程符合标准百分率为31. 4%和81. 0%(目标值为95%);微生物送检率为43. 8%(目标值为80%);用药有效率为50. 4%(目标值为80%);使用权限管理符合标准百分率73. 6%(目标值100%)。结论:本研究所建立的DUE标准可用于评价和规范注射用伏立康唑的临床合理使用。AIM:To establish the drug use evaluation(DUE)for intravenous injection(IV)administration of voriconazole and to provide reference for rational use of voriconazole.METHODS:According to voriconazole instructions and relative references,DUE criteria for IV administration of voriconazole were established.A total of 121 cases from July 2017 to July 2018 were retrospectively evaluated by the established evaluation and analyzed in respects of medication indication,medication duration,medication results,management indexes,etc.RESULTS:The results for DUE of voriconazole was that the coincidence rate of medication indication was 66.9%(target value was 90%),the rates of administration,solvent selections and preparation methods were all 100%(target value was 100%),the rates of dosage and course of treatment were 31.4%and 81.0%(target value was 95%),microbial inspection rate was 43.8%(target value was 80%),the effective rate of drug use was 50.4%(target value was 80%)and the compliance rate of authority management was 73.6%(target value was 100%).CONCLUSION:Established DUE criteria of IV administration of voriconazole can evaluate and standardize the clinical utilization of voriconazole.

关 键 词:伏立康唑 合理用药 药物利用评价 

分 类 号:R969.3[医药卫生—药理学] R978.5[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象